Year 2021 Vol. 29 No 1

REVIEWS

YU.P. ORLOV, O.V. KORPACHEVA, N.V. GOVOROVA, V.N. LUKACH, E.N. KAKULYA, G.A. BAJTUGAEVA

EVOLUTION OF POINTS OF VIEW ON HEMOTRANSFUSION FROM THE POSITION OF A PATHOPHYSIOLOGIST

Omsk State Medical University, Omsk,
The Russian Federation

A careful assessment of the risks and benefits should precede each decision to transfusion allogeneic erythrocytes. Currently, a number of important problem in transfusion medicine is very controversial, most importantly the influence of different transfusion thresholds on clinical outcome. The purpose of this article is to highlight some features regarding to effectiveness, outcomes and risks, as well as to present a new trend in the recommendations for blood transfusion. In our days there is a general consensus about the decision to transfuse blood to a specific patient should be based primarily on his/her need for global and regional oxygen delivery and consumption, i.e. on clinical assessment of signs of insufficient global and regional tissue oxygenation, which can vary significantly depending on the individual characteristics of the patient (reactivity features). Evaluation of these signs – physiological triggers of transfusion – requires a deep knowledge of the physiology and pathophysiology of blood transfusions and clinical experience. Actualization of theoretical knowledge and the formation of clinical experience on this problem will permit a physician to make decisions about blood transfusion with the lowest risk for the patient. However, quantitative criteria for individual blood indicators – numerical triggers of transfusion – can be useful in some situations, for example, when monitoring is insufficient or due to the lack of adequate sufficient experience of medical personnel.

Keywords: anemia, hemoglobin, blood transfusion, red blood cell transfusion, adverse effects, complications
p. 90-100 of the original issue
References
  1. Castaigne A. Reassessment of drugs. Rev Prat. 2002 Mar 1;52(5):507-9. [Article in French]. https://www.researchgate.net/publication/11416454_Reassessment_of_drugs
  2. Dameshek W. Editorial. Blood. 1946;1(1):83-84. doi: 10.1182/Blood.V1.1.83.83
  3. Coller BS. Blood at 70: its roots in the history of hematology and its birth. Blood. 2015 Dec 10;126(24):2548-60. doi: 10.1182/blood-2015-09-659581
  4. Goodnough LT. Blood management: transfusion medicine comes of age. Lancet. 2013 May 25;381(9880):1791-92. doi: 10.1016/S0140-6736(13)60673-X
  5. Goodnough LT, Levy JH, Murphy MF. Concepts of blood transfusion in adults. Lancet. 2013 May 25;381(9880):1845-54. doi: 10.1016/S0140-6736(13)60650-9
  6. Isbister JP. Perioperative transfusion management. Transfus Apher Sci. 2002 Aug;27(1):17. doi: 10.1016/s1473-0502(02)00022-8
  7. Schmidt PJ, Ness PM. Hemotherapy: from bloodletting magic to transfusion medicine. Transfusion. 2006 Feb;46(2):166-68. doi: 10.1111/j.1537-2995.2006.00697.x
  8. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth. 2005 Jul;95(1):33-42. doi: 10.1093/bja/aeh290
  9. Gell DA. Structure and function of haemoglobins. Blood Cells Mol Dis. 2018 May;70:13-42. doi: 10.1016/j.bcmd.2017.10.006
  10. Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, Komadina R, Maegele M, Nardi G, Riddez L, Samama CM, Vincent JL, Rossaint R. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019 Mar 27;23(1):98. doi: 10.1186/s13054-019-2347-3
  11. Jaramillo S, Montane-Muntane M, Gambus PL, Capitan D, Navarro-Ripoll R, Blasi A. Perioperative blood loss: estimation of blood volume loss or haemoglobin mass loss? Blood Transfus. 2019 Nov 27:1-11. doi: 10.2450/2019.0204-19.
  12. Miserocchi G, Bartesaghi M. Pathophysiological alterations in oxygen delivery to the tissues. Transfus Apher Sci. 2011 Dec;45(3):291-97. doi: 10.1016/j.transci.2011.10.011
  13. Demaret P, Emeriaud G, Hassan NE, Kneyber MCJ, Valentine SL, Bateman ST, Tucci M. Recommendations on RBC Transfusions in Critically Ill Children With Acute Respiratory Failure From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med. 2018 Sep;19(9S Suppl 1):S114-S120. doi: 10.1097/PCC.0000000000001619
  14. Goodnough LT, Shah N. Is there a “magic” hemoglobin number? Clinical decision support promoting restrictive blood transfusion practices. Am J Hematol. 2015 Oct;90(10):927-33. doi: 10.1002/ajh.24101
  15. Ghiani A, Sainis A, Sainis G, Neurohr C. Anemia and red blood cell transfusion practice in prolonged mechanically ventilated patients admitted to a specialized weaning center: an observational study. BMC Pulm Med. 2019 Dec 18;19(1):250. doi: 10.1186/s12890-019-1009-1
  16. Kumar A. Perioperative management of anemia: limits of blood transfusion and alternatives to it. Cleve Clin J Med. 2009 Nov;76(Suppl 4):S112-18. doi: 10.3949/ccjm.76.s4.18
  17. Hare GM, Tsui AK, Ozawa S, Shander A. Anaemia: can we define haemoglobin thresholds for impaired oxygen homeostasis and suggest new strategies for treatment? Best Pract Res Clin Anaesthesiol. 2013 Mar;27(1):85-98. doi: 10.1016/j.bpa.2012.12.002
  18. Garcia-Casal MN, Pasricha SR, Sharma AJ, Peña-Rosas JP. Use and interpretation of hemoglobin concentrations for assessing anemia status in individuals and populations: results from a WHO technical meeting. Ann N Y Acad Sci. 2019 Aug;1450(1):5-14. doi: 10.1111/nyas.14090
  19. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, Holcomb JB, Illoh O, Kaplan LJ, Katz LM, Rao SV, Roback JD, Shander A, Tobian AA, Weinstein R, Swinton McLaughlin LG, Djulbegovic B. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012 Jul 3;157(1):49-58. doi: 10.7326/0003-4819-157-1-201206190-00429
  20. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, Gernsheimer T, Holcomb JB, Kaplan LJ, Katz LM, Peterson N, Ramsey G, Rao SV, Roback JD, Shander A, Tobian AA. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016 Nov 15;316(19):2025-35. doi: 10.1001/JAMA.2016.9185
  21. Centor RM, Carson JL. Web Exclusive. Annals On Call - Outcomes of Patients Discharged With Anemia. Ann Intern Med. 2019 Mar 19;170(6):OC1. doi: 10.7326/A19-0001
  22. Franchini M, Marano G, Veropalumbo E, Masiello F, Pati I, Candura F, Profili S, Catalano L, Piccinini V, Pupella S, Vaglio S, Liumbruno GM. Patient Blood Management: a revolutionary approach to transfusion medicine. Blood Transfus. 2019 May;17(3):191-95. doi: 10.2450/2019.0109-19
  23. Graffeo C, Dishong W. Severe blood loss anemia in a Jehovah’s Witness treated with adjunctive hyperbaric oxygen therapy. Am J Emerg Med. 2013 Apr;31(4):756.e3-4. doi: 10.1016/j.ajem.2012.11.013
  24. de Araújo Azi LM, Lopes FM, Garcia LV. Postoperative management of severe acute anemia in a Jehovah’s Witness. Transfusion. 2014 Apr;54(4):1153-57. doi: 10.1111/trf.12424
  25. Dai J, Tu W, Yang Z, Lin R. Case report: intraoperative management of extreme hemodilution in a patient with a severed axillary artery. Anesth Analg. 2010 Nov;111(5):1204-6. doi: 10.1213/ANE.0b013e3181e668b8
  26. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood Transfusion. Transfusion. 2002 Jul;42(7):812-18. doi: 10.1046/j.1537-2995.2002.00123.x
  27. Tobian AA, Ness PM, Noveck H, Carson JL. Time course and etiology of death in patients with severe anemia. Transfusion. 2009 Jul;49(7):1395-99. doi: 10.1111/j.1537-2995.2009.02134.x
  28. Roberson RS, Bennett-Guerrero E. Impact of red blood cell transfusion on global and regional measures of oxygenation. Mt Sinai J Med. 2012 Jan-Feb;79(1):66-74. doi: 10.1002/msj.21284
  29. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leão WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010 Oct 13;304(14):1559-67. doi: 10.1001/JAMA.2010.1446
  30. Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, Gauvin F, Collet JP, Toledano BJ, Robillard P, Joffe A, Biarent D, Meert K, Peters MJ. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007 Apr 19;356(16):1609-19. doi: 10.1056/NEJMoa066240
  31. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med. 2014 Feb;127(2):124-31.e3. doi: 10.1016/j.amjmed.2013.09.017
  32. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet. 2007 Aug 4;370(9585):415-26. doi: 10.1016/S0140-6736(07)61197-0
  33. Lukach VN Orlov YuP, Dolgih VT, Govorova NV, Gluschenko AV, Ivanov AV. Problem of intraoperative hemoTransfusion. Anesteziologiia i Reanimatologiia. 2014;(3):20-25. https://www.elibrary.ru/item.asp?id=21669590 (In Russ.)
  34. Casutt M, Seifert B, Pasch T, Schmid ER, Turina MI, Spahn DR. Factors influencing the individual effects of blood transfusions on oxygen delivery and oxygen consumption. Crit Care Med. 1999 Oct;27(10):2194-200. doi: 10.1097/00003246-199910000-00021
  35. Zimmerman R, Tsai AG, Salazar Vázquez BY, Cabrales P, Hofmann A, Meier J, Shander A, Spahn DR, Friedman JM, Tartakovsky DM, Intaglietta M. Posttransfusion Increase of Hematocrit per se Does Not Improve Circulatory Oxygen Delivery due to Increased Blood Viscosity. Anesth Analg. 2017 May;124(5):1547-54. doi: 10.1213/ANE.0000000000002008
  36. Nielsen ND, Martin-Loeches I, Wentowski C. The Effects of red Blood Cell Transfusion on Tissue Oxygenation and the Microcirculation in the Intensive Care Unit: A Systematic Review. Transfus Med Rev. 2017 Oct;31(4):205-22. doi: 10.1016/j.tmrv.2017.07.003
  37. Hariri G, Bourcier S, Marjanovic Z, Joffre J, Lemarié J, Lavillegrand JR, Charue D, Duflot T, Bigé N, Baudel JL, Maury E, Mohty M, Guidet B, Bellien J, Blanc-Brude O, Ait-Oufella H. Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients. Crit Care. 2019 Aug 30;23(1):292. doi: 10.1186/s13054-019-2572-9
  38. Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell Transfusion. Cochrane Database Syst Rev. 2016 Oct 12;10:CD002042. doi: 10.1002/14651858.CD002042.pub4
  39. Shander A, Van Aken H, Colomina MJ, Gombotz H, Hofmann A, Krauspe R, Lasocki S, Richards T, Slappendel R, Spahn DR. Patient blood management in Europe. Br J Anaesth. 2012 Jul;109(1):55-68. doi: 10.1093/bja/aes139
  40. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology. 2010 Aug;113(2):482-95. doi: 10.1097/ALN.0b013e3181e08e97
  41. Shander A, Popovsky MA. Understanding the consequences of transfusion-related acute lung injury. Chest. 2005 Nov;128(5 Suppl 2):598S-604S. doi: 10.1378/chest.128.5_suppl_2.598S
  42. Barrett NA, Kam PC. Transfusion-related acute lung injury: a literature review. Anaesthesia. 2006 Aug;61(8):777-85. doi: 10.1111/j.1365-2044.2006.04742.x
  43. Shander A, Fink A, Javidroozi M, Erhard J, Farmer SL, Corwin H, Goodnough LT, Hofmann A, Isbister J, Ozawa S, Spahn DR. Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes. Transfus Med Rev. 2011 Jul;25(3):232-46.e53. doi: 10.1016/j.tmrv.2011.02.001
  44. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ. 2015;350:h1354. doi: 10.1136 / bmj.h1354
  45. Zil’ber AP. Krovopoteria i gemotransfuziia. Printsipy i metody beskrovnoi khirurgii. Petrozavodsk, RF: Izd. PetrGU; 1999. 120 s. https://www.booksmed.com/hirurgiya/1131-krovopoterya-i-gemotransfuziya-zilber.html (In Russ.)
Address for correspondence:
644119, Russian Federation,
Omsk, Perelet Str., 9,
City Emergency Clinical Hospital No1,
the Department of Anesthesiology
and Reanimatology,
Omsk State Medical University
tel.: +381-2-75-32-64,
å-mail: orlov-up@mail.ru,
Orlov Yurij P.
Information about the authors:
Orlov Yurij P., MD, Professor of the Department of Anesthesiology and Reanimatology, Omsk State Medical University, Omsk, Russian Federation.
http://orcid.org/0000-0002-6747-998X
Govorova Natal’ya V., MD, Professor, Head of the Department of Anesthesiology and Reanimatology, Omsk State Medical University, Omsk, Russian Federation.
http://orcid.org/0000-0002-0495-902X
Korpacheva Ol’ga V., MD, Associate Professor, Head of the Department of Pathological Physiology, Clinical Physiology, Omsk State Medical University, Omsk, Russian Federation.
http://orcid.org/0000-0001-6110-3933
Lukach Valerij N., MD, Professor of the Department of Anesthesiology and Reanimatology, Omsk State Medical University, Omsk, Russian Federation.
https://orcid.org/0000-0002-9440-3235
Kakulya Evgenij N., PhD, Assistant of the Department of Anesthesiology and Reanimatology, Omsk State Medical University, Omsk, Russian Federation.
http://orcid.org/0000-0002-2811-6051
Bajtugaeva Galina A., PhD, Associate Professor of the Department of Anesthesiology and Reanimatology, Omsk State Medical University, Omsk, Russian Federation.
https://orcid.org/0000-0002-6479-7915
Contacts | ©Vitebsk State Medical University, 2007-2023